AUM $6.4MER 0.47%NAV $31.76Holdings 68Inception Aug 2022
Price Chart
Key Statistics
Previous Close
$31.36Day Range
$31.48$31.72
52-Week Range
$27.97$40.67
Avg Volume
1.4KDividend Yield
1.00%Expense Ratio
0.47%AUM
$6.4MShares Outstanding
159.3KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 65.97% |
| Ireland | 5.21% |
| Netherlands | 4.08% |
| South Korea | 3.49% |
| Sweden | 3.43% |
| Denmark | 3.13% |
| Canada | 3.10% |
| Australia | 2.51% |
| Japan | 1.98% |
| Switzerland | 1.90% |
| India | 1.33% |
| China | 1.18% |
| France | 1.11% |
| Israel | 0.68% |
| Other | 0.62% |
| Italy | 0.29% |
Fund Information
- Issuer
- iShares
- Types
- GrowthTechnology
- Inception Date
- Aug 24, 2022
- Exchange
- NYSE_ARCA
- Description
- The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund issued by iShares that launched on Aug 24, 2022. It currently manages $6.4M in assets under management. The fund charges an expense ratio of 0.47%. The fund holds 68 securities in its portfolio.
Top 10 holdings represent 42.0% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | BIIB | BIOGEN | 5.58% | 1,396 | $354K |
| 2 | ALKS | ALKERMES | 4.65% | 6,686 | $295K |
| 3 | EWTX | EDGEWISE THERAPEUTICS | 4.50% | 7,148 | $286K |
| 4 | NBIX | NEUROCRINE BIOSCIENCES | 4.47% | 1,981 | $284K |
| 5 | PTCT | PTC THERAPEUTICS | 4.41% | 4,446 | $280K |
| 6 | ARGX | ARGENX SE ADR | 4.12% | 299 | $262K |
| 7 | SRRK | SCHOLAR ROCK HOLDING | 3.68% | 5,565 | $234K |
| 8 | PRAX | PRAXIS PRECISION MEDICINES | 3.57% | 875 | $227K |
| 9 | DNTH | DIANTHUS THERAPEUTICS | 3.52% | 2,848 | $224K |
| 10 | ACAD | ACADIA PHARMACEUTICALS | 3.52% | 10,995 | $223K |
| 11 | SUPN | SUPERNUS PHARMACEUTICALS | 3.51% | 5,299 | $223K |
| 12 | 326030.KS | SK BIOPHARMACEUTICALS LTD | 3.39% | 3,810 | $216K |
| 13 | HLUN-B.CO | H. LUNDBECK CLASS B | 3.17% | 26,061 | $201K |
| 14 | DYN | DYNE THERAPEUTICS | 3.15% | 12,682 | $200K |
| 15 | XENE | XENON PHARMACEUTICALS | 2.96% | 5,158 | $188K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +0.48% | |
| 1W | +2.62% | |
| 1M | -5.58% | |
| 3M | -14.59% | |
| 6M | -8.40% | |
| YTD | -0.59% | |
| 1Y | +4.69% | |
| 3Y | +62.96% | |
| 5Y | +28.61% |
Moving Averages
20-Day MA
$31.62
Below 20-Day MA50-Day MA
$35.30
Below 50-Day MA200-Day MA
$34.79
Below 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$40.67
Current Price
$31.52
52-Week Low
$27.97
$27.97$40.67
Current Yield
1.00%
Annual Dividend
$0.7471
Frequency
Annualx/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.3198 | Dec 19, 2025 |
| Dec 16, 2025 | $0.3198 | Dec 19, 2025 |
| Dec 17, 2024 | $0.1011 | Dec 20, 2024 |
| Dec 20, 2023 | $0.0063 | Dec 27, 2023 |
| Jun 7, 2023 | $0.0082 | Jun 13, 2023 |
Dividend Payments Over Time
Category Comparison
No category data available for comparison.
Compare with Another ETF
Search for an ETF to compare with IBRN:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.